Results 141 to 150 of about 16,129 (156)

Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome

Brain, 2007
Janice L Holton, Catherine Strand, Alan Pittman   +2 more
exaly  

Predictors of survival in a series of clinically diagnosed progressive supranuclear palsy patients

Parkinsonism and Related Disorders, 2013
Michele De Mari, Giovanni Iliceto, P Lamberti   +2 more
exaly  

Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy

Brain, 2010
Richard G Brown, L Lacomblez, Thomas H Bak   +2 more
exaly  

An Autopsy Case of Progressive Supranuclear Palsy With Incidental ATXN2 Expansion

JAMA Neurology, 2018
Ahro Kim, Sung-Hye Park, Beomseok Jeon   +2 more
exaly  

Accuracy of the national institute for neurological disorders and stroke/society for progressive supranuclear palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy

Movement Disorders, 2013
Sigrun Roeber, Hans Kretzschmar, Gunter U Höglinger   +2 more
exaly  

Social cognitive deficits and their neural correlates in progressive supranuclear palsy

Brain, 2012
Boyd C P Ghosh, Andrew J Calder, Polly V Peers   +2 more
exaly  

Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology

JAMA Neurology, 2019
Michael G Heckman, Catherine Labbé, Alexandra I Soto   +2 more
exaly  

Prevalence of progressive supranuclear palsy in Yonago, Japan

Movement Disorders, 2004
Masayoshi Kusumi
exaly  

Pharmacological Therapy in Progressive Supranuclear Palsy

Archives of Neurology, 1998
Irène Litvan, Kurt A Jellinger, M Verny   +2 more
exaly  

Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease

Brain, 2012
Helen Ling, Andrew J Lees, Peter Brown
exaly